Combination Therapy for High-risk Non-muscle-invasive Bladder Cancer (HR-NMIBC) with and without BCG Pretreatment

被引：0
|
作者：
Rexer, Heidrun [1 ]
Grimm, Marc-Oliver [2 ]
Ohlmann, Carsten-H. [3 ]
机构：
[1] AUO Geschaftsstelle, Bad Herrenalb, Germany
[2] Univ Klinikum Jena, Klin & Poliklin Urol, Jena, Germany
[3] Deutsch Krebsgesell eV, Arbeitsgemeinschaft Urol Onkol, Berlin, Germany
来源：
AKTUELLE UROLOGIE | 2024年 / 55卷 / 05期
关键词：
D O I：
10.1055/a-2365-9589
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Randomized, active-controlled phase III clinical trial to evaluate the efficacy and safety of pembroli-zumab (MK-3475) in combination with Bacillus Calmette-Gu & eacute;rin (BCG) in patients with high-risk non-muscle-invasive bladder cancer (HR-NMIBC) that persists or relapses after induction therapy with BCG and for BCG-naive patients (KEYNOTE-676)-AB 64/18 of the AUO
引用
收藏
页码：412 / 413
页数：2
相关论文
共 50 条
  • [11] Re: Erdafitinib in BCG-Treated High-Risk Non-Muscle-Invasive Bladder Cancer
    Catto, J. W. F.
    Tran, B.
    Roupret, M.
    JOURNAL OF UROLOGY, 2024, 212 (05): : 779 - 779
  • [12] Treatment of high-risk, non-muscle-invasive bladder cancer
    Seth P Lerner
    Nature Clinical Practice Urology, 2006, 3 : 398 - 399
  • [13] Treatment of high-risk, non-muscle-invasive bladder cancer
    Lerner, Seth P.
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (08): : 398 - 399
  • [14] Contemporary management of patients with high-risk non-muscle-invasive bladder cancer who fail intravesical BCG therapy
    D. R. Yates
    M. Rouprêt
    World Journal of Urology, 2011, 29 : 415 - 422
  • [15] Contemporary management of patients with high-risk non-muscle-invasive bladder cancer who fail intravesical BCG therapy
    Yates, D. R.
    Roupret, M.
    WORLD JOURNAL OF UROLOGY, 2011, 29 (04) : 415 - 422
  • [16] BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
    Lidagoster, Sarah
    Ben-David, Reuben
    De Leon, Benjamin
    Sfakianos, John P.
    CURRENT ONCOLOGY, 2024, 31 (02) : 1063 - 1078
  • [17] [18F]-FDG PET/CT FOR BLADDER CANCER STAGING AND DECISION-MAKING IN PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (HR-NMIBC)
    Hurle, Rodolfo
    Casale, Paolo
    Saita, Alberto
    Buffi, NicoloMaria
    Lughezzani, Giovanni
    Contieri, Roberto
    Fasulo, Vittorio
    Frego, Nicola
    Benetti, Alessio
    Chiti, Arturo
    Rodari, Marcello
    Sollini, Martini
    Pini, Cristiano
    Gelardi, Fabrizia
    Guazzoni, Giorgio
    Lazzeri, Massimo
    JOURNAL OF UROLOGY, 2022, 207 (05): : E1010 - E1010
  • [18] [18F]-FDG PET/CT for bladder cancer staging and decision-making in patients with High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC)
    Hurle, R.
    Gobbo, A.
    Casale, P.
    Saita, A.
    Buffi, N.
    Lughezzani, G.
    Sollini, M.
    Rodari, M.
    Pini, C.
    Gelardi, F.
    Contieri, R.
    Guazzoni, G.
    Chiti, A.
    Lazzeri, M.
    EUROPEAN UROLOGY, 2022, 81 : S358 - S359
  • [19] Novel immunotherapeutic options for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
    Hannouneh, Zein Alabdin
    Hijazi, Amjad
    Alsaleem, Alaa Aldeen
    Hami, Siwan
    Kheyrbek, Nina
    Tanous, Fadi
    Khaddour, Karam
    Abbas, Abdulfattah
    Alshehabi, Zuheir
    CANCER MEDICINE, 2023, 12 (24): : 21944 - 21968
  • [20] Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancer
    Scilipoti, Pietro
    Longoni, Mattia
    de Angelis, Mario
    Zaurito, Paolo
    Slusarczyk, Aleksander
    Soria, Francesco
    Pradere, Benjamin
    Krajewski, Wojciech
    D'Andrea, David
    Mari, Andrea
    Del Giudice, Francesco
    Pichler, Renate
    Subiela, Jose Daniel
    Marcq, Gautier
    Gallioli, Andrea
    Afferi, Luca
    Mastroianni, Riccardo
    Simone, Giuseppe
    Albisinni, Simone
    Mertens, Laura S.
    Laukhtina, Ekaterina
    Oberneder, Katharina
    Elena, Jose Luis Rodriguez
    Aranda, Javier
    Puentedura, Alfonso Lafuente
    Velasco, Jorge Cano
    Contieri, Roberto
    Hurle, Rodolfo
    Mori, Keiichiro
    Radziszewski, Piotr
    Shariat, Shahrokh F.
    Gontero, Paolo
    Necchi, Andrea
    Roupret, Morgan
    Montorsi, Francesco
    Salonia, Andrea
    Briganti, Alberto
    Moschini, Marco
    EAU YAU
    Urothelial Carcinoma Working Grp
    BJU INTERNATIONAL, 2025,
12345